Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis
J David Spence1, Victoria Coates, Hector Li
1Stroke Prevention and Atherosclerosis Research Centre, 1400 Western Road, London, Ontario, Canada. dspence@robarts.ca
Insights
Intensive medical therapy significantly reduced microemboli and cardiovascular events in patients with asymptomatic carotid stenosis (ACS). Revascularization is now less beneficial, with intensive medical management being the primary recommendation.
Area of Science:
- Vascular Medicine
- Neurology
- Cardiology
Background:
- Asymptomatic carotid stenosis (ACS) poses a risk for stroke.
- Transcranial Doppler (TCD) can detect microemboli, indicators of embolic risk.
- Previous management strategies for ACS focused on revascularization.
Purpose of the Study:
- To evaluate the impact of intensified medical therapy on TCD microemboli and cardiovascular events in ACS patients.
- To compare outcomes before and after the implementation of more intensive medical protocols since 2003.
Main Methods:
- Prospective study conducted at a teaching hospital.
- Included 468 patients with ACS (>60% stenosis).
- Compared microemboli on TCD, cardiovascular events, and carotid plaque progression rates before and after 2003.
Main Results:
- Microemboli decreased from 12.6% to 3.7% (P < .001) post-2003, correlating with better lipid control and slower plaque progression.
- Cardiovascular events (stroke, MI, death, symptomatic endarterectomy) dropped from 17.6% to 5.6% (P < .001).
- First-year carotid plaque progression rate significantly reduced from 69 mm² to 23 mm² (P < .001).
Conclusions:
- Intensified medical therapy markedly reduces cardiovascular events and microemboli in ACS patients.
- Less than 5% of ACS patients may benefit from revascularization.
- Primary recommendation for ACS patients is intensive medical therapy, with revascularization considered only if microemboli are present on TCD.
Objective:
To assess the effect of more intensive medical therapy on the rate of transcranial Doppler (TCD) microemboli and cardiovascular events in patients with asymptomatic carotid stenosis (ACS).
Design:
A prospective study.
Setting:
A teaching hospital.
Patients:
Four hundred sixty-eight patients with ACS greater than 60% by Doppler peak velocity.
Main Outcome Measures:
We compared (1) the proportion of ACS patients who had microemboli on TCD, (2) cardiovascular events, (3) rate of carotid plaque progression, and (4) baseline medical therapy, before and since 2003.
Results:
Among 468 ACS patients, 199 were enrolled between January 1, 2000, and December 31, 2002; and 269 were enrolled between January 1, 2003, and July 30, 2007. Microemboli were present in 12.6% before 2003 and 3.7% since 2003 (P < .001). The decline in microemboli coincided with better control of plasma lipids and slower progression of carotid total plaque area. Since 2003, there have been significantly fewer cardiovascular events among patients with ACS: 17.6% had stroke, death, myocardial infarction, or carotid endarterectomy for symptoms before 2003, vs 5.6% since 2003 (P < .001). The rate of carotid plaque progression in the first year of follow-up has declined from 69 mm(2) (SD, 96 mm(2)) to 23 mm(2) (SD, 86 mm(2)) (P < .001).
Conclusions:
Cardiovascular events and microemboli on TCD have markedly declined with more intensive medical therapy. Less than 5% of patients with ACS now stand to benefit from revascularization; patients with ACS should receive intensive medical therapy and should only be considered for revascularization if they have microemboli on TCD.
Related Concept Videos
Atherosclerosis III: Management
Ischemic Stroke l: Introduction
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Mitral Stenosis III: Medical Management

